array-based genome-wide dna methylation analysis Search Results


90
INFINIUM Inc 450k bead array
Genome Wide DNA Methylation Assays.
450k Bead Array, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pmc05394941-139-11-10?v=INFINIUM+Inc
Average 90 stars, based on 1 article reviews
450k bead array - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
Thermo Fisher dna methylation analysis
Genome Wide DNA Methylation Assays.
Dna Methylation Analysis, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pm28848059-49-2-22?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
dna methylation analysis - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
INFINIUM Inc array-based infinium beadchip
Genome Wide DNA Methylation Assays.
Array Based Infinium Beadchip, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pmc04881129-49-8-7?v=INFINIUM+Inc
Average 90 stars, based on 1 article reviews
array-based infinium beadchip - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AKESOgen Inc array-based platforms
Genome Wide DNA Methylation Assays.
Array Based Platforms, supplied by AKESOgen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/10__1038_slash_labinvest__2014__31-660-15-10?v=AKESOgen+Inc
Average 90 stars, based on 1 article reviews
array-based platforms - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
WholeGenome LLC wholegenome bisulfite sequencing
Genome Wide DNA Methylation Assays.
Wholegenome Bisulfite Sequencing, supplied by WholeGenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pm30160951-10-29-14?v=WholeGenome+LLC
Average 90 stars, based on 1 article reviews
wholegenome bisulfite sequencing - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
INFINIUM Inc snp array 6.0
Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping <t>(SNP6</t> array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.
Snp Array 6.0, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pmc09487591-8-11-28?v=INFINIUM+Inc
Average 90 stars, based on 1 article reviews
snp array 6.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Active Motif antibody against 5hmc
Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping <t>(SNP6</t> array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.
Antibody Against 5hmc, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pmc04603372-301-11-2?v=Active+Motif
Average 90 stars, based on 1 article reviews
antibody against 5hmc - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
INFINIUM Inc microarray medip-chip infinium platform
Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping <t>(SNP6</t> array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.
Microarray Medip Chip Infinium Platform, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pmc03422781-700-15-17?v=INFINIUM+Inc
Average 90 stars, based on 1 article reviews
microarray medip-chip infinium platform - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

98
Illumina Inc miniseq
Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping <t>(SNP6</t> array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.
Miniseq, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/us12480164-120-144-145?v=Illumina+Inc
Average 98 stars, based on 1 article reviews
miniseq - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

96
Illumina Inc infinium methylationepic bead chip array
Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping <t>(SNP6</t> array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.
Infinium Methylationepic Bead Chip Array, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pm35892159-58-1-5?v=Illumina+Inc
Average 96 stars, based on 1 article reviews
infinium methylationepic bead chip array - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

86
10X Genomics small interfering rna sirna
Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping <t>(SNP6</t> array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.
Small Interfering Rna Sirna, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array-based+genome-wide+dna+methylation+analysis/pmc07735660-311-137-116?v=10X+Genomics
Average 86 stars, based on 1 article reviews
small interfering rna sirna - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Genome Wide DNA Methylation Assays.

Journal: Pediatric diabetes

Article Title: DNA Methylation and its Role in the Pathogenesis of Diabetes

doi: 10.1111/pedi.12521

Figure Lengend Snippet: Genome Wide DNA Methylation Assays.

Article Snippet: Various studies have mapped genome wide DNA methylation using the Infinium 450k bead array or MeDIP in placentae from women with GDM and have found increased number of differentially methylated genes predominantly involved in glucose metabolism pathway and in energy metabolism ( 80 – 83 ).

Techniques: Genome Wide, DNA Methylation Assay, Methylation, Next-Generation Sequencing

Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.

Journal: Briefings in Bioinformatics

Article Title: Refinement of computational identification of somatic copy number alterations using DNA methylation microarrays illustrated in cancers of unknown primary

doi: 10.1093/bib/bbac161

Figure Lengend Snippet: Computational prediction of SCNA from DNA methylation arrays using conumee- K CN . ( A ) Workflow for the developed strategy to refine SCNA detection, ‘conumee- K CN ’, trained over 442 primary tumor samples from TCGA, across 18 cancer types, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. Our thresholding strategy refines conumee outputs and quantitatively calls SCNA from 450K arrays by considering tumor purity ρ (RF_Purity) and rigorous estimation of copy-number-state ( CN )-dependent constants K CN . * A list of 94 genes frequently amplified or deleted in cancer was used as reference to define the copy number states. Thus, by using calibrated K CN ’s and considering tumor purity, intra-sample variability and copy-number-state-dependent noise, thresholds for each CN can be estimated for each 450K profiled sample to accurately identify SCNA. ( B ) Benchmarking of our strategy (conumee- K CN ) against conumee (fixed threshold of 0.3), cnAnalysis450k and ChAMP in an independent, validation set consisting of 151 TCGA samples, with matched genotyping (SNP6 array) and DNA methylation array (450K) data. True positive (TP) and false-positive (FP) rates of 450K-derived calls versus SNP6-derived calls (ASCAT) for amplifications are depicted, showing the improved performance of our approach. ( C ) TP and FP rates of conumee- K CN versus ASCAT in the TCGA validation set for the three amplification copy number states (Amp10, Amp and Gain). ( D ) Representative examples of gene amplifications in two samples from the TCGA validation cohort. Thresholds estimated by conumee- K CN for Amp and Amp10 are depicted (dotted grey lines). TP = #𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝑇𝑟u𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝐹𝑎l𝑠𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠; FP = #𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠/#𝐹𝑎l𝑠𝑒 p𝑜𝑠𝑖𝑡𝑖v𝑒𝑠 + #𝑇𝑟u𝑒 𝑁𝑒g𝑎𝑡𝑖v𝑒𝑠.

Article Snippet: In recent years, as a potential alternative to the use of SNP-based SNP Array 6.0 (SNP6) arrays, several approaches to detect genome-wide Somatic Copy Number Alterations (SCNAs) from Infinium Human Methylation 450K/EPIC arrays have been developed [ ] and are applied in several fields, including cancer research [i.e. ].

Techniques: DNA Methylation Assay, Amplification, Biomarker Discovery, Derivative Assay